Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An insulin-producing neuroendocrine tumor arising from the beta cells of the pancreas. Patients exhibit symptoms related to hypoglycemia due to inappropriate secretion of insulin.
Biomarker and diagnostic research for pancreatic insulinoma has been reported in the published literature.
9 clinical trials registered, 5 recruiting. Interventions under study include other interventions, drug therapy, and procedural interventions. Pipeline includes 1 PHASE2, 1 PHASE1, 2 NA. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT03583528](https://clinicaltrials.gov/study/NCT03583528) |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 8:39 AM UTC
DOTATOC PET/CT for Imaging NET Patients |
— |
British Columbia Cancer Agency |
ACTIVE_NOT_RECRUITING |
[NCT01824875](https://clinicaltrials.gov/study/NCT01824875) | Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors | PHASE2 | ECOG-ACRIN Cancer Research Group | UNKNOWN |
[NCT06725693](https://clinicaltrials.gov/study/NCT06725693) | Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease | — | Tianjin Medical University | RECRUITING |
[NCT00001276](https://clinicaltrials.gov/study/NCT00001276) | Diagnosing and Treating Low Blood Sugar Levels | — | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | RECRUITING |
[NCT05735912](https://clinicaltrials.gov/study/NCT05735912) | EUS-RFA Versus Surgery for Pancreatic Insulinoma (ERASIN-RCT) | NA | Azienda Ospedaliera Universitaria Integrata Verona | ACTIVE_NOT_RECRUITING |
188 publications have been identified in PubMed for pancreatic insulinoma. Research spans Case Report / Case Series (31%), Review / Meta-Analysis (22%), and Basic Science / Preclinical (20%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 54 | 31% |
Research summaries | 38 | 22% |
Laboratory research | 35 | 20% |
Testing and diagnosis research | 14 | 8% |
Clinical study results | 14 | 8% |
Disease patterns and progression | 10 | 6% |
Other research | 5 | 3% |
New treatment approaches | 5 | 3% |
Polavarapu S (2026). [PMID: 41725241](https://pubmed.ncbi.nlm.nih.gov/41725241/). *J Biochem Mol Toxicol*. [Clinical Trial Publication]
Bruni A (2026). [PMID: 41748131](https://pubmed.ncbi.nlm.nih.gov/41748131/). *J Gastroenterol Hepatol*. [Review / Meta-Analysis]
Pournejati R (2026). [PMID: 41537432](https://pubmed.ncbi.nlm.nih.gov/41537432/). *Elife*. [Basic Science / Preclinical]
Kovacevic B (2026). [PMID: 41120112](https://pubmed.ncbi.nlm.nih.gov/41120112/). *J Clin Endocrinol Metab*. [Case Report / Case Series]
Katsuda H (2026). [PMID: 41389876](https://pubmed.ncbi.nlm.nih.gov/41389876/). *Cell Mol Gastroenterol Hepatol*. [Basic Science / Preclinical]
Gehlbach DL (2026). [PMID: 42238165](https://pubmed.ncbi.nlm.nih.gov/42238165/). *Cureus*. [Case Report / Case Series]
Rekha A (2026). [PMID: 41371328](https://pubmed.ncbi.nlm.nih.gov/41371328/). *Clin Chim Acta*. [Review / Meta-Analysis]
van Baal L (2026). [PMID: 41448958](https://pubmed.ncbi.nlm.nih.gov/41448958/). *Diabetes Obes Metab*. [Clinical Trial Publication]
Zhao W (2026). [PMID: 41641296](https://pubmed.ncbi.nlm.nih.gov/41641296/). *AACE Endocrinol Diabetes*. [Case Report / Case Series]
Li Y (2026). [PMID: 41748371](https://pubmed.ncbi.nlm.nih.gov/41748371/). *Pancreatology*. [Basic Science / Preclinical]
AI-curated news mentioning pancreatic insulinoma
Updated Jun 12, 2026
A case report highlights hypoglycemic encephalopathy caused by insulinoma, revealing reversible high signals in the white matter on diffusion-weighted MRI. This finding may enhance understanding of neurological impacts associated with insulinoma.
A case report highlights the occurrence of insulinoma complicated by hypergastrinemia in a patient with type 2 diabetes mellitus. This finding may provide insights into the complex interactions between these conditions.